JPRN-UMIN000010957已完成未知
Investigation of anti-tumoral effect and safety of combination therapy LD-GP (low dose gemcitabine and paclitaxel) therapy and sorafenib in patients with cisplatin-resistant advanced urothelial cancer. - Efficacy and safety of combination therapy of low dose gemcitabine and paclitaxeltherapy with sorafenib in patients with cisplatin-resistant urothelial cancer.
agasaki University Hospital0 个研究点目标入组 15 人开始时间: 2013年6月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Blood examinations WBC: under 3,000 / mm3. Neut: under 1,500 / mm3. Plt: under 100,000/ mm3. Hgb: under 8 g/dl. T-Bil: over 1.5 mg/dl. s-Cr: over 2.0 mg/dl.
研究者
相似试验
招募中
1 期
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma.Liver NeoplasmsCarcinoma, HepatocellularDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialHepatocellular carcinomaRPCEC00000022Center of Molecular Immunology (CIM)15
招募中
1 期
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment.Primary malignant colon and breast lesion and metastatic liver lesions.Liver NeoplasmsDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesRPCEC00000023Center of Molecular Immunology (CIM)15
已完成
2 期
An investigation of antitumor effectiveness using M-VAC/CaG prediction system in neoadjuvant chemotherapy for muscle invasive bladder cancer.Muscle-invasive bladder cancerJPRN-UMIN000019902Department of Urology, Iwate Medical University35
招募中
Unknown
Autologous Vax-NK/HCC Consolidation Therapy in Patients with Extensive Stage Small Cell Lung CancerNeoplasmsKCT0008301Chonnam National University Hospital Hwasun Hospital12
招募中
不适用
The study on the antitumor effect of medication for underlying diseases of the patients with unresectable pancreatic carcinoma who undergo standard chemotherapy.JPRN-UMIN000022938ara Medical University40